|
|
||||||||
Technical Briefs |
Departments of1 Critical Care Medicine and2 Laboratory Medicine, Warren Magnuson Clinical Center, NIH, Bethesda, MD
aaddress correspondence to this author at: Department of Laboratory Medicine, NIH, Bldg. 10, Room 2C-407, Bethesda, MD 20892-1508; fax 301-402-1885, e-mail ghortin@mail.cc.nih.gov
| The first 300 words of the full text of this article appear below. |
Currently, there are high degrees of both enthusiasm and controversy regarding the potential diagnostic application of matrix-assisted laser desorption/ionization time-of-flight (MALDI TOF) mass spectrometry (1)(2)(3)(4)(5)(6)(7). This technique permits the simultaneous analysis of a large number of polypeptide components in biological fluids. Greatest sensitivity and resolution are achieved by MALDI TOF mass spectrometry in the mass range from
500 to 20 000 Da; this has led to the recognition that there is a highly complex mixture of peptide components in serum that circulate bound to larger proteins (8)(9). The complex patterns of peptide components are very information rich and may contain multiple biomarkers of diagnostic value (1)(2)(3)(4)(5)(6)(7)(8)(9).
The present study examined whether different types of blood collection tubes add molecules to specimens that may appear as interfering or confounding peaks during MALDI TOF mass spectrometry. Commercially available blood collection tubes contain multiple components that may shed polymers in the molecular size range of interest. Silicones are commonly used as lubricants for stoppers or coatings for the internal surface of tubes. Polymeric surfactants such as polyvinylpyrrolidones or polyethylene glycols may be added to influence surface wetting. Tubes may contain either clot inhibitors or activators. Serum separator tubes contain polymeric gels with several constituents to adjust viscosity, density, and other physical properties. Rubber stoppers and the plastics comprising tube walls may shed polymeric components or plasticizers. Previous studies have reported effects of blood collection tubes on a variety of laboratory tests (10)(11)(12)(13)(14). These effects can arise from adsorption of serum or plasma components to the tube or
The following articles in journals at HighWire Press have cited this article:
![]() |
F. Mannello Serum or Plasma Samples?: The "Cinderella" Role of Blood Collection Procedures Preanalytical Methodological Issues Influence the Release and Activity of Circulating Matrix Metalloproteinases and Their Tissue Inhibitors, Hampering Diagnostic Trueness and Leading to Misinterpretation Arterioscler. Thromb. Vasc. Biol., April 1, 2008; 28(4): 611 - 614. [Full Text] [PDF] |
||||
![]() |
D. McLerran, W. E. Grizzle, Z. Feng, W. L. Bigbee, L. L. Banez, L. H. Cazares, D. W. Chan, J. Diaz, E. Izbicka, J. Kagan, et al. Analytical Validation of Serum Proteomic Profiling for Diagnosis of Prostate Cancer: Sources of Sample Bias Clin. Chem., January 1, 2008; 54(1): 44 - 52. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A.R. Bowen, S. K. Drake, R. Vanjani, E. D. Huey, J. Grafman, and M. K. Horne III Markedly Increased Vitamin B12 Concentrations Attributable to IgG-IgM-Vitamin B12 Immune Complexes. Clin. Chem., November 1, 2006; 52(11): 2107 - 2114. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Pilny, P. Bouchal, S. Borilova, P. Ceskova, J. Zaloudik, R. Vyzula, B. Vojtesek, and D. Valik Surface-Enhanced Laser Desorption Ionization/Time-of-Flight Mass Spectrometry Reveals Significant Artifacts in Serum Obtained from Clot Activator-Containing Collection Devices. Clin. Chem., November 1, 2006; 52(11): 2115 - 2116. [Full Text] [PDF] |
||||
![]() |
G. L. Hortin The MALDI-TOF Mass Spectrometric View of the Plasma Proteome and Peptidome Clin. Chem., July 1, 2006; 52(7): 1223 - 1237. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A.R. Bowen, Y. Chan, M. E. Ruddel, G. L. Hortin, G. Csako, S. J. Demosky Jr, and A. T. Remaley Immunoassay Interference by a Commonly Used Blood Collection Tube Additive, the Organosilicone Surfactant Silwet L-720 Clin. Chem., October 1, 2005; 51(10): 1874 - 1882. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Banks, A. J. Stanley, D. A. Cairns, J. H. Barrett, P. Clarke, D. Thompson, and P. J. Selby Influences of Blood Sample Processing on Low-Molecular-Weight Proteome Identified by Surface-Enhanced Laser Desorption/Ionization Mass Spectrometry Clin. Chem., September 1, 2005; 51(9): 1637 - 1649. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Baumann, U. Ceglarek, G. M. Fiedler, J. Lembcke, A. Leichtle, and J. Thiery Standardized Approach to Proteome Profiling of Human Serum Based on Magnetic Bead Separation and Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry Clin. Chem., June 1, 2005; 51(6): 973 - 980. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A.R. Bowen, Y. Chan, J. Cohen, N. N. Rehak, G. L. Hortin, G. Csako, and A. T. Remaley Effect of Blood Collection Tubes on Total Triiodothyronine and Other Laboratory Assays Clin. Chem., February 1, 2005; 51(2): 424 - 433. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Hortin Can Mass Spectrometric Protein Profiling Meet Desired Standards of Clinical Laboratory Practice? Clin. Chem., January 1, 2005; 51(1): 3 - 5. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |